Prognostic value of MACC1 in digestive system neoplasms: A systematic review and meta-analysis

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Wu, Zhenzhen ^a   Zhou, Rui ^a   Su, Yuqi ^a   Sun, Li ^a   Liao, Yulin ^a   Liao, Wangjun ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PROGNOSIS; DIGESTIVE SYSTEM TUMOR; GENE EXPRESSION; HAZARD RATIO; HUMAN; META ANALYSIS; METASTASIS ASSOCIATED IN COLON CANCER 1 GENE; ONCOGENE; OVERALL SURVIVAL; QUALITY CONTROL; RECURRENCE FREE SURVIVAL; REVIEW; SYSTEMATIC REVIEW; BIOSYNTHESIS; DISEASE FREE SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; METASTASIS; PATHOLOGY; PROGNOSIS; TUMOR RECURRENCE;

MACC1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

BIOMARKERS, TUMOR; DIGESTIVE SYSTEM NEOPLASMS; DISEASE-FREE SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; TRANSCRIPTION FACTORS;

EID: 84930654309     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/252043     Document Type: Review

References (38)

1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, "Global cancer statistics," CA-Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69-90, 2011.
2. L. Ng, R. T. P. Poon, and R. Pang, "Biomarkers for predicting future metastasis of human gastrointestinal tumors," Cellular and Molecular Life Sciences, vol. 70, no. 19, pp. 3631-3656, 2013.
3. U. Stein, W. Walther, F. Arlt et al., "MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis," Nature Medicine, vol. 15, no. 1, pp. 59-67, 2009.
4. F. Galimi, D. Torti, F. Sassi et al., "Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to Met inhibition in patient xenografts and pathologic correlations," Clinical Cancer Research, vol. 17, no. 10, pp. 3146-3156, 2011.
5. L. Wang, Y. Wu, L. Lin et al., "Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion," International Journal of Cancer, vol. 133, no. 6, pp. 1419-1430, 2013.
6. A. Pichorner, U. Sack, D. Kobelt et al., "In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice," Clinical and Experimental Metastasis, vol. 29, no. 6, pp. 573-583, 2012.
7. L. Lin, H. Huang, W. Liao et al., "MACC1 supports human gastric cancer growth under metabolic stress by enhancing the Warburg effect," Oncogene, 2014.
8. L. Sun, J. Duan, Y. Jiang et al., "Metastasis-associated in colon cancer-1 upregulates vascular endothelial growth factor-C/D to promote lymphangiogenesis in human gastric cancer," Cancer Letters, vol. 357, no. 1, pp. 242-253, 2015.
9. M. Zhu, Y. Xu,X.Mao,Y.Gao,L. Shao, and F.Yan, "Overexpression of metastasis-associated in colon cancer-1 associated with poor prognosis in patients with esophageal cancer," Pathology &Oncology Research, vol. 19, no. 4, pp. 749-753, 2013.
10. J. L. Qiu, P. Huang, Q. Liu et al., "Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma," Journal of Translational Medicine, vol. 9, article 166, 2011.
11. G.Wang, Z. Fu, andD. Li, "MACC1 overexpression and survival in solid tumors: a meta-analysis," Tumor Biology, vol. 36, no. 2, pp. 1055-1065, 2015.
12. U. Stein, S. Burock, P. Herrmann et al., "Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis," PLoS ONE, vol. 7, no. 11,Article ID e49249, 2012.
13. U. S. Stein, S. Fuchs, C. M. Monoranu et al., "MACC1 as biomarker for progression and prognosis of human malignant glioma," Cancer Research, vol. 72, no. 8, 2012.
14. X. H. Zhang, W. Z. Jiang, and G. X. Guan, "Expression of MACC1 protein in rectal adenocarcinoma and its clinical significance,"Medical Innovation of China, vol. 9, no. 18, pp. 24-26, 2012.
15. A.-D. Kang, F. Fang, Y.-P. Deng, N.-N. Gao, and G.-B. Hu, "Expression and clinicopathological significance of MACC1 in colon cancer," Progress in Modern Biomedicine, vol. 13, no. 26, pp. 5087-5090, 2013.
16. T.Zhen, S. Dai, H. Li et al., "MACC1 promotes carcinogenesis of colorectal cancer via β-catenin signaling pathway," Oncotarget, vol. 5, no. 11, pp. 3756-3769, 2014.
17. S.-H. Ge, X.-J. Wu, X.-H. Wang et al., "Over-expression of metastasis-associated in colon cancer-1 (MACC1) associates with better prognosis of gastric cancer patients," Chinese Journal of Cancer Research, vol. 23, no. 2, pp. 153-159, 2011.
18. T. K. Guo, J. Yang, J. Yao, Y. Zhang, M. Da, and Y. Duan, "Expression ofMACC1 and c-Met in human gastric cancer and its clinical significance," Cancer Cell International, vol. 13, no. 1, article 121, 2013.
19. Y.-P. Yang, J.-H. Qu, X.-J. Chang et al., "High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma," Journal of Translational Medicine, vol. 11, article 41, 2013.
20. J. H. Qu, X. J. Chang, Y. Y. Lu et al., "Overexpression of metastasis-associated in colon cancer 1 predicts a poor outcome of hepatitis B virus-related hepatocellular carcinoma," World Journal of Gastroenterology, vol. 18, no. 23, pp. 2995-3003, 2012.
21. F. Ding, J. Gao, S. Han, X. Wang, Q. Liu, and Y. Yao, "Expression of MACC1 protein in hepatocellular carcinoma and its relationship with the prognosis of patients," Acta Medicinae Universitatis Scientiae et Technologiae Huazhong, vol. 42, no. 4, pp. 464-468, 2013.
22. C. Xie, J.Wu, J. Yun et al., "MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma," PLoS ONE, vol. 8, no. 5,Article ID e64235, 2013.
23. D. Ji, Z.-T. Lu, Y.-Q. Li et al., "MACC1 expression correlates with PFKFB2 and survival in hepatocellular carcinoma," Asian Pacific Journal of Cancer Prevention, vol. 15, no. 2, pp. 999-1003, 2014.
24. S. Gao, B.-Y. Lin, Z. Yang et al., "Role of overexpression of MACC1 and/or FAK in predicting prognosis of hepatocellular carcinoma after liver transplantation," International Journal of Medical Sciences, vol. 11, no. 3, pp. 268-275, 2014.
25. C. Isella, A. Mellano, F. Galimi et al., "MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases," Annals of Surgery, vol. 257, no. 6, pp. 1089-1095, 2013.
26. M. Kawamura, S. Saigusa, Y. Toiyama et al., "Correlation of MACC1 andMET expression in rectal cancer after neoadjuvant chemoradiotherapy," Anticancer Research, vol. 32, no. 4, pp. 1527-1531, 2012.
27. J. F. Tierney, L. A. Stewart, D. Ghersi, S. Burdett, and M. R. Sydes, "Practical methods for incorporating summary time-toevent data into meta-analysis," Trials, vol. 8, article 16, 2007.
28. G.Wells, B. Shea, D. O'Connell et al., "The newcastle-Ottawa Scale (nOS) for assessing the quality of nonrandomised studies inmeta-analyses," 2000, http://www.ohri.ca/programs/clinical epidemiology/oxford.asp.
29. W.C.W.Wong, C. S. K. Cheung, and G. J. Hart, "Development of a quality assessment tool for systematic reviews of observational studies (QATSO) of HIV prevalence in men having sex with men and associated risk behaviours," Emerging Themes in Epidemiology, vol. 5, article 23, 2008.
30. J. P. T. Higgins, S. G.Thompson, J. J. Deeks, and D. G. Altman, "Measuring inconsistency in meta-analyses," British Medical Journal, vol. 327, no. 7414, pp. 557-560, 2003.
31. M. Egger, G. D. Smith, M. Schneider, and C. Minder, "Bias in meta-analysis detected by a simple, graphical test," British Medical Journal, vol. 315, no. 7109, pp. 629-634, 1997.
32. D. Moher, A. Liberati, J. Tetzlaff, D. G. Altman, and The PRISMA Group, "Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement," Annals of Internal Medicine, vol. 151, no. 4, pp. 264-269, 2009.
33. A. Shirahata, K. Shinmura, Y. Kitamura et al., "MACC1 as a marker for advanced colorectal carcinoma," Anticancer Research, vol. 30, no. 7, pp. 2689-2692, 2010.
34. N. Harpaz, S. Taboada, H. M. Ko et al., "Expression of MACC1 and MET in inflammatory bowel disease-associated colonic neoplasia," Inflammatory Bowel Diseases, vol. 20, no. 4, pp. 703-711, 2014.
35. A. Shirahata, M. Sakata, Y. Kitamura et al., "MACC 1 as a marker for peritoneal-disseminated gastric carcinoma," Anticancer Research, vol. 30, no. 9, pp. 3441-3444, 2010.
36. G. Wang, M.-X. Kang, W.-J. Lu, Y. Chen, B. Zhang, and Y.-L. Wu, "MACC1: a potential molecule associated with pancreatic cancer metastasis and chemoresistance," Oncology Letters, vol. 4, no. 4, pp. 783-791, 2012.
37. A. Shirahata, W. Fan, K. Sakuraba et al., "MACC 1 as a marker for vascular invasive hepatocellular carcinoma," Anticancer Research, vol. 31, no. 3, pp. 777-780, 2011.
38. K.Wang, Q. Jiang, and J. Yu, "Expressionof MACC-1 in human colon cancer and its clinical significance," Chinese Clinical Oncology, vol. 17, no. 12, pp. 1081-1084, 2012.